A $27.5 Billion Industry Opportunity with Laxatives Accounting for $12.3 Billion

Home A $27.5 Billion Industry Opportunity with Laxatives Accounting for $12.3 Billion
Written by Doug Hampton
On

DUBLIN, June 19, 2023 /PRNewswire/ — The “Constipation Treatment: Global Strategic Business Report” report has been added to  ResearchAndMarkets.com’s offering.

Global Constipation Treatment Market to Reach $27.5 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Constipation Treatment estimated at US$17.3 billion in the year 2022, is projected to reach a revised size of US$27.5 billion by 2030, growing at a CAGR of 5.9% over the analysis period 2022-2030. Laxatives, one of the segments analyzed in the report, is projected to record 6.4% CAGR and reach US$12.3 billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Chloride Channel Activators segment is readjusted to a revised 4.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $4.6 Billion, While China is Forecast to Grow at 9% CAGR

The Constipation Treatment market in the U.S. is estimated at US$4.6 billion in the year 2022. China, the world’s second largest economy, is forecast to reach a projected market size of US$6.4 billion by the year 2030 trailing a CAGR of 9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 5.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Select Competitors (Total 41 Featured)

  • Abbott
  • AbbVie’s Inc.
  • Albireo Pharma, Inc.
  • AstraZeneca
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cosmo Pharma
  • Daewoong
  • Ironwood Pharmaceuticals
  • Janssen Pharmaceutical
  • Mallinckrodt PLC
  • Prestige Brands
  • Renexxion
  • Sanofi
  • Shionogi
  • Takeda Pharmaceutical Company Limited

What’s New for 2023?

  • Special coverage on RussiaUkraine war; global inflation; easing of zero-COVID policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies – Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and an online research platform
  • Complimentary updates for one year

Key Attributes

Report Attribute

Details

No. of Pages

194

Forecast Period

2022-2030

Estimated Market Value (USD) in 2022

$17.3 Billion

Forecasted Market Value (USD) by 2030

$27.5 Billion

Compound Annual Growth Rate

6 %

Regions Covered

Global

Key Topics Covered

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Constipation Treatment – Global Key Competitors Percentage Market Share in 2022 (E)
  • Impact of COVID-19 and a Looming Global Recession
  • Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/ivgo0e

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets

Leave a Comment